List of works - Iván Alvarez-Twose

Adherence to immunotherapy in times of financial crisis

scientific article published on 20 April 2013

An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.

scientific article published on 4 November 2011

Anaphylaxis as a clinical manifestation of clonal mast cell disorders.

scientific article

Bone Marrow Expression of Mast Cell Disorders

scientific article published on 01 August 2018

Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis ⬇️

scientific article published on 28 January 2019

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis

scientific article published on 20 September 2013

Characterization of CD34+ hematopoietic cells in systemic mastocytosis: potential role in disease dissemination.

scientific article published on 13 January 2018

Childhood mastocytosis

scientific article published on 01 August 2012

Clinical impact of pregnancy in mastocytosis: a study of the Spanish Network on Mastocytosis (REMA) in 45 cases

scientific article published on 30 March 2011

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

scientific article published in June 2010

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.

scientific article published on 19 June 2015

Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia.

scientific article published on 15 February 2016

Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions

scientific article published on 01 September 2012

Current state of biology and diagnosis of clonal mast cell diseases in adults.

scientific article published on 03 May 2012

Cutaneous Mastocytosis With Predominant Infiltration of Promastocytes

scientific article published on 01 April 2019

Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors

scientific article published on 17 May 2018

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

scientific article published on 15 October 2015

Dermoscopic features of skin lesions in patients with mastocytosis

scientific article published on 01 August 2011

Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications

scientific article published on 12 June 2015

Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients.

scientific article published on 12 October 2015

Evaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxis ⬇️

scientific article published on November 10, 2010

Evaluation of the WHO criteria for the classification of patients with mastocytosis.

scientific article published on 6 May 2011

Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(-) mesenchymal stem cells in human bone marrow

scientific article

Extensive blistering is a predictor for severe complications in children with mastocytosis

scientific article published on 01 October 2012

Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool

scientific article published on May 2014

Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis

scientific article published on 31 May 2019

Fulminant necrotizing fasciitis caused by Serratia marcescens in an immunosuppressed host

scientific article published on 29 May 2012

IgE-mediated anaphylaxis to Hippobosca equina in a patient with systemic mastocytosis.

scientific article published on 11 December 2009

Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.

scientific article

Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression

scientific article published on 8 July 2015

Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis ⬇️

scientific article published on March 28, 2012

Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis ⬇️

scientific article published on April 1, 2011

Insights in Anaphylaxis and Clonal Mast Cell Disorders.

scientific article

KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression.

scientific article published on 30 November 2015

Management of Anesthesia in Adult and Pediatric Mastocytosis: A Study of the Spanish Network on Mastocytosis (REMA) Based on 726 Anesthetic Procedures.

scientific article published on 9 July 2015

Mast Cells as Key Players in Allergy and Inflammation

scientific article published on 01 December 2018

Mast cell activation disorders presenting with cerebral vasospasm-related symptoms: a "Kounis-like" syndrome?

scientific article published on 01 June 2011

Mast cell-related disorders presenting with Kounis syndrome

scientific article published on 29 June 2012

Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.

scientific article published on 12 January 2010

Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features

scientific article published on 01 March 2022

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.

scientific article published on 6 August 2013

Perioperative anaphylaxis in a patient with a solitary mastocytoma

scientific article published on 10 March 2019

Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)

scientific article published on 01 October 2007

Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.

scientific article

Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome

scientific article published on 05 February 2019

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.

scientific article published on 19 May 2014

Response to celecoxib in a patient with indolent systemic mastocytosis presenting with intractable diarrhea

scientific article published on 01 November 2015

Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.

scientific article published on 4 January 2008

Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome

scientific article

Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis.

scientific article published on 21 September 2013

Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis.

scientific article

Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: A report of two cases

scientific article published on 14 February 2015

Systemic mastocytosis presenting as occupational IgE-mediated anaphylaxis to pine processionary caterpillar.

scientific article published on 27 July 2016

The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis

scientific article

Tryptase increase on the first day of hymenoptera venom immunotherapy might be a predictor of future systemic reactions during treatment.

scientific article published on 28 March 2018

Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations.

scientific article published on 30 August 2013

Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.

scientific article published on May 2011

List of works by Iván Alvarez-Twose

Adherence to immunotherapy in times of financial crisis

An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.

Anaphylaxis as a clinical manifestation of clonal mast cell disorders.

Bone Marrow Expression of Mast Cell Disorders

Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis ⬇️

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis

Characterization of CD34+ hematopoietic cells in systemic mastocytosis: potential role in disease dissemination.

Childhood mastocytosis

Clinical impact of pregnancy in mastocytosis: a study of the Spanish Network on Mastocytosis (REMA) in 45 cases

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.

Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia.

Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions

Current state of biology and diagnosis of clonal mast cell diseases in adults.

Cutaneous Mastocytosis With Predominant Infiltration of Promastocytes

Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

Dermoscopic features of skin lesions in patients with mastocytosis

Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications

Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients.

Evaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxis ⬇️

Evaluation of the WHO criteria for the classification of patients with mastocytosis.

Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(-) mesenchymal stem cells in human bone marrow

Extensive blistering is a predictor for severe complications in children with mastocytosis

Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool

Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis

Fulminant necrotizing fasciitis caused by Serratia marcescens in an immunosuppressed host

IgE-mediated anaphylaxis to Hippobosca equina in a patient with systemic mastocytosis.

Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.

Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression

Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis ⬇️

Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis ⬇️

Insights in Anaphylaxis and Clonal Mast Cell Disorders.

KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression.

Management of Anesthesia in Adult and Pediatric Mastocytosis: A Study of the Spanish Network on Mastocytosis (REMA) Based on 726 Anesthetic Procedures.

Mast Cells as Key Players in Allergy and Inflammation

Mast cell activation disorders presenting with cerebral vasospasm-related symptoms: a "Kounis-like" syndrome?

Mast cell-related disorders presenting with Kounis syndrome

Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.

Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.

Perioperative anaphylaxis in a patient with a solitary mastocytoma

Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)

Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.

Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.

Response to celecoxib in a patient with indolent systemic mastocytosis presenting with intractable diarrhea

Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.

Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome

Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis.

Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis.

Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: A report of two cases

Systemic mastocytosis presenting as occupational IgE-mediated anaphylaxis to pine processionary caterpillar.

The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis

Tryptase increase on the first day of hymenoptera venom immunotherapy might be a predictor of future systemic reactions during treatment.

Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations.

Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.